SARS-CoV-2 is a SARS-like coronavirus of likely zoonotic origin first identified in December
2019 in Wuhan, the capital of China's Hubei province. The virus has since spread globally, …

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) rapidly spread around the
globe after its emergence in Wuhan in December 2019. With no specific therapeutic and …

Background Favipiravir and Molnupiravir, orally available antivirals, have been reported to
exert antiviral activity against SARS-CoV-2. First efficacy data have been recently reported in …

Results The maximum likelihood phylogeny of 13 pediatric SARS-CoV-2 cases and 130
SARS-CoV-2 sequences generated from community cases across North London is shown in Fig …

Severe acute respiratory syndrome‐coronavirus 2 (SARS‐CoV‐2) viral loads change rapidly
following symptom onset, so to assess antivirals it is important to understand the natural …

Cytomegalovirus (CMV) is the commonest cause of congenital infection and particularly so
among infants born to HIV-infected women. Studies of congenital CMV infection (cCMVi) …

… Florencia AT Boshier and Juanita Pang contributed equally to this study as co-first authors.
… Florencia AT Boshier and Juanita Pang wrote the manuscript, generated all figures, selected …

Chronic human norovirus (HuNoV) infections in immunocompromised patients result in
severe disease, yet approved antivirals are lacking. RNA-dependent RNA polymerase (RdRp) …

Mutagenic antiviral drugs have shown promise against multiple viruses, but concerns have
been raised about whether their use might promote the emergence of new and harmful viral …

Longitudinal deep sequencing of viruses can provide detailed information about intra-host
evolutionary dynamics including how viruses interact with and transmit between hosts. Many …